Evidence map›Paper›PMID 24287374›Full record

ArticleNeuroscience letters2014

Antidepressant effects on serotonin 1A/1B receptors in the rat brain using a gene x environment model.

Stal Saurav Shrestha, Daniel S Pine, David A Luckenbaugh, Katarina Varnäs, Ioline D Henter, Robert B Innis, Aleksander A Mathé, Per Svenningsson

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Precision Medicine in Antidepressants Treatment.Handbook of experimental pharmacology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. The 5-HTPsychopharmacology · 2018
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Stal Saurav ShresthaDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA. Electronic address: shresthas@mail.nih.gov.
Daniel S PineMolecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA.
David A LuckenbaughMolecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA.
Katarina VarnäsDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ioline D HenterMolecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA.
Robert B InnisMolecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA.
Aleksander A MathéDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
National Institute of Mental Health · USKarolinska Institutet · SE

Funding

Translational Evaluation Of PET RadiotracersZIAMH002795 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI INNIS, ROBERT · 2009 to 2025
$32.0M
Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

A gene-environment (GxE) interaction is implicated in both the pathophysiology and treatment of major depressive disorder (MDD). This study modeled the effects of genetic vulnerability by using the Flinders sensitive line (FSL), a rat model of depression and its control counterpart-the Flinders resistant line (FRL). The effects of environmental vulnerability (e.g., early-life stress) were modeled by using maternal separation. Rats (n=105) were drawn from four groups reflecting experimental crossing of strain (FSL vs. FRL) and early-life stress (high vs. low) to assess the effects of two antidepressants (escitalopram or nortriptyline) compared to vehicle. Quantitative in vitro autoradiography was performed using [(125)I]MPPI (5-HT1A) and [(125)I]CYP (5-HT1B) in prefrontal cortex (PFC) and hippocampus. Stringent, Bonferroni-corrected statistical analyses showed significant strain-by-rearing-by-treatment (three-way) interactions in PFC 5-HT1A and hippocampal 5-HT1B receptors. Either vulnerability reduced serotonergic binding; no additive effects were associated with the two vulnerabilities. Both antidepressants increased hippocampal 5-HT1B receptor binding; however, only nortriptyline selectively increased PFC 5-HT1A receptor binding. Taken together, our findings demonstrate that antidepressant effects on the serotonergic system are shaped by a GxE interaction that depends on antidepressant class and brain region.

Indexed as

Gene-Environment InteractionSocial EnvironmentAnimalsAntidepressive AgentsBrain ChemistryDepressionDisease Models, AnimalFemaleGenes, X-LinkedMaleMaternal DeprivationProtein BindingRatsRats, TransgenicReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT1BAntidepressive AgentsReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT1BEscitalopramFSL/FRL (Flinders sensitive/resistant line)Gene-environment (GxE)HippocampusNortriptylinePFC (prefrontal cortex)Serotonin 1A/1B (5-HT(1A/1B)) receptors

Identifiers

PMID24287374
PMCPMC4204401
OpenAlexW2044516074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.